ARTICLE | Company News
PharmaMar, Ortho Biotech in cancer deal
August 10, 2001 7:00 AM UTC
The companies will co-develop PharmaMar's ET-743, a cytotoxic alkaloid derived from a marine organism, to treat a variety of cancers. Johnson & Johnson (JNJ) subsidiary Ortho Biotech Products will mar...